Urinary tract infectionsNeu
Die Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.
- Mann oder Frau
- 18-55 jaar
Clinical trial of a compound that is being developed in combination with other medicinal products for the treatment of bone marrow disorders in which the body is not able to produce enough healthy blood cells.
During the trial your heart rhythm will be continuously monitored during certain moments. You will be given electrodes (small, plastic patches) on your chest and abdomen that are connected to a portable device.
Conditions for participation
Do you have a vaccination appointment planned, or have you recently been vaccinated and do you want to know whether you can participate in this study? Feel free to contact us to discuss the possibilities.
The trial consists of 1 period during which you will stay in the research facility in Groningen for 21 days (20 nights). The follow-up will take place on the day of discharge from the clinic.
|3||28 Jul 2021 up to and including 17 Aug 2021|
|4||4 Aug 2021 up to and including 24 Aug 2021|
|5||29 Sep 2021 up to and including 19 Oct 2021|
|6||6 Oct 2021 up to and including 26 Oct 2021|
PLEASE NOTE: You must be available for all dates to be able to participate in this study. The current dates of the study will be published on our website. These are the currently planned dates; however, these may be subject to change.
You will receive a gross compensation of € 3277 for participation in one of the groups of this study. In addition travelling expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per round trip, regardless of the mode of transportation.